Research Article

Fluconazole-Like Compounds as Potential Antifungal Agents: QSAR, Molecular Docking, and Molecular Dynamics Simulation

Table 1

Chemical structure of fluconazole like compounds and their experimental and cross validated-predicted activity by (GA-PLS) and their docking binding energies .

NoR1R2nExp. pMIC (μM)Pred. pMIC by GA-PLS (μM)B. E (kcal/Mol)NoR1R2nExp. pMIC (μM)Pred. pMIC by GA-PLS (μM)B.E (kcal/Mol)

1HH7.817.29-10.3502-NO26.606.61-7.5
2H2-F8.418.15-10.4513-NO27.217.17-9.6
3H3-F7.816.94-10.8524-NH26.606.20-7.1
4H4-F7.207.03-9.3532-NH26.606.41-7
5H2-Cl8.417.52-10.7543-NH26.006.22-7.3
6H3-Cl7.207.57-9.5554-NHCOPh6.606.72-7.7
7H4-Cl7.207.33-9.4564-NHCOCH36.607.02-7.6
8H3,4-Cl7.207.22-9.1576.906.31-7.7
9H3-Br7.207.30-9.5586.906.43-7.6
10H4-Br7.206.97-9.3596.906.98-7.6
11H4-CH37.207.81-9.5606.306.37-7.5
12H3,4-OCH37.818.37-9.1616.906.98-7.4
13H2,5-OCH37.817.99-9625.106.37-7.7
14CH32-NO27.817.68-9.2635.105.35-7.8
15CH33-NO27.817.82-9.5645.405.96-7.5
16CH34-NO27.207.42-9.1655.105.59-7.6
17H3-CN7.817.48-9.3665.405.20-7.5
18FH6.606.90-8.4675.705.57-7.2
19F2-F6.606.79-8.5686.906.66-7.9
20F3-F6.606.70-7.5696.616.56-7.3
21F4-F6.606.76-7.4706.306.29-7.5
22F2-Cl6.006.87-7.5715.105.11-7.2
23F3-Cl6.006.55-7.6725.405.30-8.2
24F4-Cl6.606.53-7.6736.906.66-7.7
25F3,4-Cl6.006.54-7.6746.906.43-7.9
26F3-Br6.006.22-7.6756.906.92-7.8
27F4-Br6.606.74-7.4767.206.82-8
28F4-CH36.607.05-7.6776.607.24-7.9
29F3,4-OCH36.607.05-7.2787.907.78-10.1
30F2,5-OCH37.217.11-9.1796.907.34-7
31F2-NO26.607.15-7.9806.906.92-6.8
32F3-NO28.418.27-10.981H6.006.00-8.4
33F4-NO27.816.76-10.3822-OCH36.606.45-7.8
34F3-CN6.606.71-8.7834-C(CH3)36.605.53-6.9
3537.816.76-8.8843,4 - di Cl6.605.80-7.8
3646.606.71-6.8853-Cl-4-CH36.606.49-7.8
3757.207.31-8.9864-Cl6.606.06-8.6
384-CH37.817.93-10.3874-NO25.45.02-7.5
393-CH37.817.81-10882,5 di Cl7.817.81-8.1
402-CH37.207.78-8.7892,4 di CH36.006.16-7.9
413-Br7.817.48-8.9903,4 di CH36.005.98-7.3
424-F7.817.19-8.9913-Cl-4-F6.005.49-8.5
432-Cl7.207.54-9.1923, 5-di CH36.005.47-8
444-Br7.817.85-9.9934-Br6.006.12-8.5
454NO27.207.16-9.4944-F6.005.37-8.6
464-C(CH3)37.817.85-9.3954-OCF36.606.73-8.4
474-Cl7.817.82-9.9963-OCF35.415.41-8
482-Br7.207.26-9.1974-CH34.804.77-7.8
494-OCH2Ph7.217.19-9.3

Test set development and validation of the model.